Comment: We received many comments on the proposed 12-month lookback period referenced in these definitions, as well as on the proposed definitions of the allowed amounts and how to calculate them when the percentiles fall between two observed allowed amounts
40 In patients with T2DM, the SURPASS-2 trial compared tirzepatide with semaglutide 1 mg (both as add-on therapies to metformin) and found tirzepatide was either noninferior or superior at all doses (5 mg, 10 mg 15 mg), for both HbA 1c reduction and weight loss at 40 weeks
The patient versions are written in easy-to-understand, nontechnical language
Budget approximately 10% to 15% additional peptide beyond theoretical requirements
Furthermore, professional quality assurance systems help preserve long-term product stability and dependable analytical performance
The associated risk factors (erectile dysfunction, diabetes mellitus, cigarette smoking, arterial hypertension, and so on) require longer treatment to obtain a good result
